Motif Bio PLC General Meeting -- Dial in Details (6878B)

TIDMMTFB

RNS Number : 6878B

Motif Bio PLC

11 June 2021

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN MOTIF BIO PLC OR ANY OTHER ENTITY IN ANY JURISDICTION.

Motif Bio plc

("Motif" or the "Company")

General Meeting - Dial in Details

Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM Rule 15 cash shell, provides Shareholders with details of how they can join the General Meeting which will take place at 12 p.m. (UK time) on 14 June 2021 at the offices of Reed Smith LLP, 599 Lexington Avenue, New York, NY 10022, United States.

Any Shareholders wishing to join the General Meeting should use the following dial in details:

   --    Dial in number: +1 (862) 902-0240 
   --    Passcode: 735-9754

Shareholders are also reminded that as all Resolutions to be voted on at the General Meeting are conditional, all Resolutions must be approved for the Acquisition to proceed. Motif Bio plc will not be able to continue operations in the absence of the Acquisition. As a result, if all Resolutions are not approved by Shareholders, it is expected that Motif's AIM Admission will be cancelled as soon as practicable following the General Meeting and Shareholders will receive no further value.

Capitalised terms used in this announcement carry the same meanings as those ascribed to them in the Company's Admission Document dated 26 May 2021 and/or the Company's announcement of 26 May 2021, unless the context requires otherwise.

For further information please contact:

 
                                                       ir@motifbio.com 
   Motif Bio plc 
 Jonathan Gold (Non-Executive Director) 
                                              ------------------------ 
 
 SP Angel Corporate Finance LLP (NOMAD 
  & BROKER)                                       +44 (0) 20 3470 0470 
                                              ------------------------ 
 David Hignell/Caroline Rowe (Corporate 
  Finance) 
                                              ------------------------ 
 Vadim Alexandre/Rob Rees (Sales & Broking) 
                                              ------------------------ 
 
 Walbrook PR Ltd. (UK FINANCIAL PR & 
  IR)                                             +44 (0) 20 7933 8780 
                                              ------------------------ 
 Paul McManus/ Lianne Cawthorne                motifbio@walbrookpr.com 
                                              ------------------------

Forward-Looking Statements

This announcement may contain forward-looking statements. Words such as "expects", "anticipates", "may", "should", "would", "could", "will", "intends", "plans", "believes", "targets", "seeks", "estimates", "aims", "projects", "pipeline" and variations of such words and similar expressions are intended to identify such forward-looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate transactions and involve certain risks, uncertainties, outcomes of negotiations and due diligence and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements or expectations. Among the factors that could cause actual results to differ materially are: the general economic climate, competition, interest rate levels, loss of key personnel, the result of legal and commercial due diligence and changes in the legal or regulatory environment.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOGKZGMVFMZGMZM

(END) Dow Jones Newswires

June 11, 2021 09:59 ET (13:59 GMT)

Motif Bio (LSE:MTFB)
Historical Stock Chart
From Oct 2024 to Nov 2024